[3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor.

Thomsen, C; Valsborg, J S; Platou, J; Martin, J; Foged, C; Johansen, N L; Olsen, U B; Madsen, K

Thomsen, C; Valsborg, J S; Platou, J; Martin, J; Foged, C; Johansen, N L; Olsen, U B; Madsen, K.

Affiliation

Thomsen C; Department of Molecular Pharmacology, Novo Nordisk A/S, Måløv, Denmark. CTho@lundbeck.com

Naunyn Schmiedebergs Arch Pharmacol ; 362(6): 538-45, 2000 Dec.

Article in En | MEDLINE | ID: mdl-11138846

Subject(s)

Oligopeptides/metabolism; Receptors, Opioid/metabolism; Amygdala/metabolism; Animals; Autoradiography; Binding Sites; Binding, Competitive; Cell Membrane/metabolism; Cerebral Cortex/metabolism; Cricetinae; Female; Humans; Hypothalamus/metabolism; Kinetics; Oligopeptides/pharmacology; Opioid Peptides/metabolism; Opioid Peptides/pharmacology; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid/agonists; Substrate Specificity; Tritium; Nociceptin Receptor

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Receptors, Opioid Limits: Animals / Female / Humans Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2000 Document type: Article Affiliation country: Denmark Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links